Literature DB >> 7887446

Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.

M Barral-Netto1, J S da Silva, A Barral, S Reed.   

Abstract

Resistance to and recovery from leishmania infection is dependent on cell-mediated immunity. C57BL/6 mice are resistant to Leishmania amazonensis (La) infection but susceptible to LP-BM5 murine leukemia virus (MuLV) infection. MuLV infection leads to a state of immunodeficiency characterized by severe compromise of cell-mediated immunity. When infected with La alone, C57BL/6 mice developed a small transient lesion that evolved to spontaneous healing or a lesion with extremely slow growth. Lesions were predominantly comprised of a lympho-macrophagic infiltrate with few parasitized macrophages. When infected with La and, 4 weeks later, with MuLV (La-MuLV), the mice developed a large uncontrolled nonhealing lesion containing vacuolated and heavily parasitized macrophages. In contrast, mice infected with MuLV first and La 4 weeks later (MuLV-La) developed a small but persistent lesion, characterized histologically by a small number of heavily parasitized macrophages and few lymphocytes. Eight weeks after MuLV infection, both had similar immunological profiles with decreased lymphocyte proliferation, diminished production of interferon-gamma, and high production of interleukins 4 and 10. At the time of L. amazonensis infection, La-MuLV animals have a normal T cell function whereas in MuLV-La mice this function is already impaired; this may influence the recruitment of macrophages to the site of leishmania injection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887446      PMCID: PMC1869162     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies.

Authors:  R Molina; R López-Vélez; B Gutiérrez-Solar; I Jiménez; J Alvar
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Sep-Oct       Impact factor: 2.184

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Visceral leishmaniasis in AIDS with gastric involvement.

Authors:  F Coppola; S Recchia; A Ferrari; L Del Sedime
Journal:  Gastrointest Endosc       Date:  1992 Jan-Feb       Impact factor: 9.427

4.  Gastric localization of systemic leishmaniasis in a patient with AIDS.

Authors:  L Delsedime; F Coppola; G Mazzucco
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

5.  Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment.

Authors:  S Fenske; H J Stellbrink; H Albrecht; H Greten
Journal:  Klin Wochenschr       Date:  1991-10-31

6.  Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections.

Authors:  J S Silva; M Barral-Netto; S G Reed
Journal:  Am J Trop Med Hyg       Date:  1993-11       Impact factor: 2.345

7.  Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS.

Authors:  A M Da-Cruz; E S Machado; J A Menezes; M S Rutowitsch; S G Coutinho
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Sep-Oct       Impact factor: 2.184

8.  Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.

Authors:  R T Gazzinelli; J W Hartley; T N Fredrickson; S K Chattopadhyay; A Sher; H C Morse
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Peripheral intramonocytic leishmanias in an AIDS patient.

Authors:  G Fillola; J X Corberand; P F Laharrague; H Levenes; P Massip; P Recco
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

10.  CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice.

Authors:  R T Gazzinelli; M Makino; S K Chattopadhyay; C M Snapper; A Sher; A W Hügin; H C Morse
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

View more
  10 in total

1.  Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors:  H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Qualitative and quantitative immunohistochemical evaluation of iNOS expression in the spleen of dogs naturally infected with Leishmania chagasi.

Authors:  Fernando Rocha dos Santos; Paula Melo Abreu Vieira; Rodrigo Correa-Oliveira; Rodolfo Cordeiro Giunchetti; Claudia Martins Carneiro; Alexandre Barbosa Reis; Luiz Cosme Cotta Malaquias
Journal:  Parasitol Res       Date:  2010-12-29       Impact factor: 2.289

3.  Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.

Authors:  N A Giese; R T Gazzinelli; J K Actor; R A Morawetz; M Sarzotti; H C Morse
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Parasites and immunotherapy: with or against?

Authors:  Hossein Yousofi Darani; Morteza Yousefi; Marzieh Safari; Rasool Jafari
Journal:  J Parasit Dis       Date:  2014-08-31

5.  Low-dose UVB contributes to host resistance against Leishmania amazonensis infection in mice through induction of gamma interferon and tumor necrosis factor alpha cytokines.

Authors:  Noor Mohammad Khaskhely; Motoyoshi Maruno; Hiroshi Uezato; Atsushi Takamiyagi; Saeef Taher Ramzi; Khan Mohammad Al-Kasem; Ken-ichi Kariya; Takayoshi Toda; Yoshihisa Hashiguchi; Eduardo A Gomez Landires; Shigeo Nonaka
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.

Authors:  A Fournet; M E Ferreira; A Rojas De Arias; S Torres De Ortiz; S Fuentes; H Nakayama; A Schinini; R Hocquemiller
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

8.  Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania major.

Authors:  T M Doherty; N Giese; H C Morse; R L Coffman
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection.

Authors:  Manohar B Mutnal; Scott J Schachtele; Shuxian Hu; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2013-07-31       Impact factor: 8.322

10.  Distinct cellular migration induced by Leishmania infantum chagasi and saliva from Lutzomyia longipalpis in a hemorrhagic pool model.

Authors:  Camila Oliveira Vasconcelos; Zirlane C Branco Coêlho; Cristina de Souza Chaves; Clarissa Romero Teixeira; Margarida M Lima Pompeu; Maria Jania Teixeira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.